{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:31:34Z","timestamp":1790188294139,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K43TW011095"],"award-info":[{"award-number":["K43TW011095"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K43TW011418"],"award-info":[{"award-number":["K43TW011418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA221204"],"award-info":[{"award-number":["U54CA221204"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ijid.2022.12.009","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T09:38:47Z","timestamp":1670751527000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-4128","authenticated-orcid":false,"given":"Owen","family":"Ngalamika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-6595","authenticated-orcid":false,"given":"Salum J.","family":"Lidenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Claire","family":"Mukasine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musonda","family":"Kawimbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0181-3535","authenticated-orcid":false,"given":"Patrick","family":"Kamanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Ngowi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Mwaiselage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"For Yue","family":"Tso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.12.009_bib0001","first-page":"e7423","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update","volume":"12","author":"Pal","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ijid.2022.12.009_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252617","article-title":"Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis","volume":"16","author":"Bobrovitz","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2022.12.009_bib0003","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s40001-021-00596-6","article-title":"Successive waves of COVID 19: confinement effects on virus-prevalence with a mathematical model","volume":"26","author":"Abdalla","year":"2021","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ijid.2022.12.009_bib0004","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/postgradmedj-2020-138564","article-title":"Three waves of the COVID-19 pandemic","volume":"97","author":"Fisayo","year":"2021","journal-title":"Postgrad Med J"},{"issue":"3","key":"10.1016\/j.ijid.2022.12.009_bib0005","article-title":"Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis","volume":"19","author":"Danwang","year":"2022","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.ijid.2022.12.009_bib0006","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijid.2022.12.009_bib0007","doi-asserted-by":"crossref","first-page":"e03647","DOI":"10.1128\/mBio.03647-20","article-title":"Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis","volume":"12","author":"Ng","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.ijid.2022.12.009_bib0008","doi-asserted-by":"crossref","first-page":"e1912","DOI":"10.6061\/clinics\/2020\/e1912","article-title":"Susceptibility of the elderly to SARS-CoV-2 infection: ACE-2 overexpression, shedding, and antibody-dependent enhancement (ADE)","volume":"75","author":"Peron","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ijid.2022.12.009_bib0009","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cmi.2021.06.023","article-title":"Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV research network cohort","volume":"27","author":"Berenguer","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2022.12.009_bib0010","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1016\/S2352-3018(21)00070-9","article-title":"Overview of SARS-CoV-2 infection in adults living with HIV","volume":"8","author":"Ambrosioni","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijid.2022.12.009_bib0011","doi-asserted-by":"crossref","unstructured":"Davies MA. HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa. medRxiv 03 July 2020. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.07.02.20145185v2 accessed 22 August 2022.","DOI":"10.1101\/2020.07.02.20145185"},{"key":"10.1016\/j.ijid.2022.12.009_bib0012","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1016\/S2352-3018(21)00151-X","article-title":"Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study","volume":"8","author":"Jassat","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijid.2022.12.009_bib0013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ijid.2022.12.009_bib0014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.192.3.347","article-title":"Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2","volume":"192","author":"Scanga","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijid.2022.12.009_bib0015","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.4049\/jimmunol.179.12.8243","article-title":"CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses","volume":"179","author":"Novy","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2022.12.009_bib0016","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood-2012-07-442558","article-title":"Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production","volume":"121","author":"Chiang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2022.12.009_bib0017","first-page":"e02243","article-title":"Impaired cytotoxic CD8\u00a0+\u00a0T cell response in elderly COVID-19 patients","volume":"11","author":"Westmeier","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ijid.2022.12.009_bib0018","doi-asserted-by":"crossref","first-page":"392","DOI":"10.14348\/molcells.2021.0075","article-title":"Humoral immunity against SARS-CoV-2 and the impact on COVID-19 pathogenesis","volume":"44","author":"Lee","year":"2021","journal-title":"Mol Cells"},{"key":"10.1016\/j.ijid.2022.12.009_bib0019","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41423-021-00774-w","article-title":"Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects","volume":"19","author":"Zheng","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ijid.2022.12.009_bib0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ijid.2022.12.009_bib0021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2022.12.009_bib0022","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMoa2105000","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants","volume":"384","author":"Hacisuleyman","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.12.009_bib0023","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaci.2021.10.014","article-title":"SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults","volume":"149","author":"Bj\u00f6rkander","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijid.2022.12.009_bib0024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1473-3099(21)00676-9","article-title":"Protective immunity after recovery from SARS-CoV-2 infection","volume":"22","author":"Kojima","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.009_bib0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2022.12.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00285-2021","article-title":"Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2 specific T-cells","volume":"59","author":"Riou","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2022.12.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149125","article-title":"Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection","volume":"131","author":"Riou","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijid.2022.12.009_bib0028","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1038\/s41467-021-26137-7","article-title":"Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV","volume":"12","author":"Alrubayyi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2022.12.009_bib0029","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/v13010109","article-title":"Domains and functions of spike protein in Sars-Cov-2 in the context of vaccine design","volume":"13","author":"Xia","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2022.12.009_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.663688","article-title":"SARS CoV-2 nucleoprotein enhances the infectivity of lentiviral spike particles","volume":"11","author":"Mishra","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijid.2022.12.009_bib0031","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016175","article-title":"The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles","volume":"296","author":"Boson","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijid.2022.12.009_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101041","article-title":"The SARS-CoV-2 Nsp3 macrodomain reverses PARP9\/DTX3L-dependent ADP-ribosylation induced by interferon signaling","volume":"297","author":"Russo","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijid.2022.12.009_bib0033","article-title":"Variations in Orf3a protein of SARS-CoV-2 alter its structure and function","volume":"26","author":"Azad","year":"2021","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.ijid.2022.12.009_bib0034","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021785118","article-title":"Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein","volume":"118","author":"Flower","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2022.12.009_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708264","article-title":"SARS-CoV-2 accessory proteins in viral pathogenesis: knowns and unknowns","volume":"12","author":"Redondo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2022.12.009_bib0036","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijid.2020.10.104","article-title":"High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa","volume":"102","author":"Tso","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.009_bib0037","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.12.009_bib0038","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149150","article-title":"First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19","volume":"131","author":"Mazzoni","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijid.2022.12.009_bib0039","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijid.2021.05.034","article-title":"Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals","volume":"108","author":"Sasikala","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.009_bib0040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41590-021-00902-8","article-title":"Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection","volume":"22","author":"Zuo","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ijid.2022.12.009_bib0041","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijid.2021.12.309","article-title":"SARS-COV-2 Memory B and T cells Profile in Mild COVID-19 Convalescents subjects","volume":"115","author":"Gurevich","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.009_bib0042","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/infdis\/jiab543","article-title":"Durability of SARS-CoV-2-Specific T-cell responses at 12 months postinfection","volume":"224","author":"Lu","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.009_bib0043","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jmii.2020.09.005","article-title":"Antibody response to SARS-CoV-2 in people living with HIV","volume":"54","author":"Yamamoto","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2022.12.009_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100734","article-title":"Antibody titers against SARS-CoV-2 decline, but do not disappear for several months","volume":"32","author":"Yamayoshi","year":"2021","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.ijid.2022.12.009_bib0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/hiv.13037","article-title":"Immune deficiency is a risk factor for severe COVID-19 in people living with HIV","volume":"22","author":"Hoffmann","year":"2021","journal-title":"HIV Med"},{"key":"10.1016\/j.ijid.2022.12.009_bib0046","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/QAD.0000000000003017","article-title":"Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV","volume":"35","author":"Ruddy","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2022.12.009_bib0047","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqaa007","article-title":"T cell phenotypes in COVID-19 - a living review","volume":"2","author":"Hanna","year":"2021","journal-title":"Oxf Open Immunol"},{"key":"10.1016\/j.ijid.2022.12.009_bib0048","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1590\/1806-9282.66.12.1666","article-title":"Comparative evaluation of memory T cells in COVID-19 patients and the predictive role of CD4+CD8+ double positive T lymphocytes as a new marker","volume":"66","author":"Kalpakci","year":"2020","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.ijid.2022.12.009_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225415","article-title":"Naive\/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: a multicenter study","volume":"14","author":"Bordoni","year":"2019","journal-title":"PLoS One"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222006464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222006464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:10:53Z","timestamp":1761120653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222006464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":49,"alternative-id":["S1201971222006464"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.12.009","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}